-
movement disorders.
Antidyskinetic drugs can be used to
treat dyskinesia.
Certain anticonvulsants can be used as
antidyskinetic agents,
among drugs acting...
- Kloiber, I.; Haubenberger, D.; Auff, E.; Poewe, W. (2010). "Long-term
antidyskinetic efficacy of
amantadine in Parkinson's Disease".
Movement Disorders....
- Amantadine, sold
under the
brand name
Gocovri among others, is a
medication used to
treat dyskinesia ****ociated with
parkinsonism and
influenza caused...
- Deutetrabe****ne (trade name Austedo) is a
vesicular monoamine transporter 2
inhibitor which is used for the
treatment of c****a ****ociated with Huntington's...
-
share the
antidyskinetic effects of amantadine. However,
findings are conflicting, and some data
suggest that
memantine may also have
antidyskinetic effects...
- Tetrabe****ne is a drug for the
symptomatic treatment of
hyperkinetic movement disorders. It is sold
under the
brand names Nitoman and Xe****ne
among others...
- Valbe****ne, sold
under the
brand name Ingrezza, is a
medication used to
treat tardive dyskinesia. It acts as a
vesicular monoamine transporter 2 (VMAT2)...
- 3-Methylmethcathinone (3-MMC), also
known as metaphedrone, is a
designer drug from the
substituted cathinone family. 3-MMC is a
monoamine transporter substrate...
- Levetiracetam, sold
under the
brand name
Keppra among others, is a
novel antiepileptic drug (medication) used to
treat epilepsy. It is used for partial-onset...
-
effects than
conventional dopamine receptor antagonists. Specifically,
antidyskinetic and
antipsychotic effects with
fewer or no
motor side
effects was sought...
